机译:血清YKL-40是高级胶质瘤的预后和疾病状态的标志
The Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY,Neuro-Oncology Branch, National Cancer Institute and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD;
The Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY;
The Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY;
Department of Epidemiology-Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY;
Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY;
Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY;
Department of Epidemiology-Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY;
The Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY;
The Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY;
Department of Clinical Laboratories, Memorial Sloan-Kettering Cancer Center, New York;
The Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY;
The Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY;
The Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY,Department of Oncology, Geneva University Hospital, Geneva, Switzerland;
glioblastoma; glioma; serum marker ykl-40;
机译:小儿高级神经胶质瘤的组织学分级,p53状态,YKL-40表达和IDH1突变的预后意义。
机译:小儿高级别神经胶质瘤的组织学分级,p53状态,YKL-40表达和IDH1突变的预后意义
机译:基于动态敏感性对比度灌注MRI的血管栖息地分析预测高级胶质瘤的IDH突变状态和预后
机译:疾病过程脑胶质瘤脑胶质瘤脑胶质术后凋亡和细胞凋亡的肝细胞化学和分子标记及治疗疗效
机译:YKL-40是胶质母细胞瘤的血管相关血清标志物,与AKT的慢性活化有关。
机译:血清YKL-40是高级胶质瘤的预后和疾病状态的标志
机译:血清YKL-40是高档胶质瘤中预后和疾病状态的标志物